No Data
No Data
10-K/A: Annual report (Amendment)
Express News | SeaStar Medical Holding Corp -Files Prospectus Relates to Offer & Resale, From Time to Time, of up to 3.5 Mln Shares by Selling Securityholder
Express News | FDA Grants SeaStar Medical Two New Breakthrough Device Designations for Scd Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
Maxim Group Maintains SeaStar Medical(ICU.US) With Buy Rating, Announces Target Price $7
SeaStar Medical Holdings: Buy Rating Driven by Clinical Milestones and Market Expansion Opportunities
Q4 2024 SeaStar Medical Holding Corp Earnings Call